Dubai, UAE - April 28th, 2026 - Symbiotic and Midas have unveiled a new product designed to unlock liquidity for tokenized assets. Built on Symbiotic Core V2 and integrated into Midas’ Open Liquidity Architecture, the solution offers Request for Quote (RFQ) settlement with T+0 atomic settlement, eliminating idle capital and pre-funded inventory.
Currently, many tokenized assets suffer from illiquidity, with redemptions taking months. This new partnership addresses this by allowing asset managers to submit redemption requests, which Symbiotic-registered market makers can bid on via an onchain RFQ system. The best bid executes, and settlement occurs in a single transaction, freeing up capital.
Midas CEO Dennis Dinkelmeyer stated, "The biggest friction point for tokenised products has always been redemptions. Symbiotic Instant Liquidity changes that equation."
Symbiotic Core V2 enables capital within its vaults to remain enforceable yet deployed between settlement events. This capital can be allocated to whitelisted DeFi protocols and automatically recalled when obligations trigger, facilitating instant settlement.
Fasanara’s mGLOBAL fund, tokenized on Midas, is the first asset live on Symbiotic Instant Liquidity. This system also manages lending market liquidations, a historical constraint in DeFi.
Misha Putiatin, Co-Founder of Symbiotic, added, "Liquidity is what turns an asset class into a market. Committed capital now functions as a liquidity sleeve, settling redemptions without sitting idle."
Symbiotic provides collateral markets infrastructure for credit, insurance, and RWAs, backed by major investors. Midas offers composable onchain investment products, enabling the tokenization of institutional strategies with instant redemptions.